Literature DB >> 12014418

Suspected HNPCC and Amsterdam criteria II: evaluation of mutation detection rate, an international collaborative study.

Jae-Gahb Park1, Hans F A Vasen, Young Jin Park, Kyu Joo Park, Paivi Peltomaki, Maurizio Ponzo de Leon, Miguel A Rodriguez-Bigas, Jan Lubinski, Nicholas E Beck, Marie-Luise Bisgaard, Michiko Miyaki, Juul T Wijnen, Shozo Baba, Annika Lindblom, Lisa Madlensky, Henry T Lynch.   

Abstract

BACKGROUND AND AIMS: The Korean Hereditary Tumor Registry has proposed criteria for suspected hereditary nonpolyposis colorectal cancer (S-HNPCC criteria I and II) and confirmed their validity in an international collaborative study. The S-HNPCC criteria included families that did not fulfill the Amsterdam criteria, but in whom HNPCC was nevertheless strongly suspected. The S-HNPCC criteria was also revised accordingly since some S-HNPCC families now fullfil the revised Amsterdam criteria. The original Amsterdam criteria have recently been revised, including some extracolonic cancers. This study compared the mutation detection rates between the revised and previous Amsterdam and S-HNPCC criteria. PATIENTS AND METHODS: Data on the mutational status of 393 HNPCC suspected families were collected from ten different institutes. Two hundred families were categorized into old S-HNPCC criteria (142 into criteria I and 58 into criteria II) and 193 families into Amsterdam criteria I.
RESULTS: Of the 142 old S-HNPCC criteria I families 24 fulfilled the Amsterdam criteria II as the data were reclassified according to the revised criteria, increasing the proportion of the families fulfilling the Amsterdam criteria by 12.4%. The mutation detection rate of the revised criteria was very little changed compared to the old criteria; 26% and 27% in the S-HNPCC criteria, and 50% and 52% in the Amsterdam criteria.
CONCLUSION: The mutation detection rate is hardly affected by the revision of the Amsterdam criteria although the population of patients fulfilling the criteria is increased. The value of revised S-HNPCC criteria is equivalent to that of as the old S-HNPCC criteria in selecting of candidate patients for genetic testing.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12014418     DOI: 10.1007/s003840100348

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  27 in total

1.  Microsatellite instability testing in Korean patients with colorectal cancer.

Authors:  Jung Ryul Oh; Duck-Woo Kim; Hye Seung Lee; Hee Eun Lee; Sung Min Lee; Je-Ho Jang; Sung-Bum Kang; Ja-Lok Ku; Seung-Yong Jeong; Jae-Gahb Park
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

2.  History of the International Collaborative Group on Hereditary Non Polyposis Colorectal Cancer.

Authors:  Henry T Lynch; Giuseppe Cristofaro; Paul Rozen; Hans Vasen; Patrick Lynch; Jukka-Pekka Mecklin; Jim St John
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

3.  Genetic counseling outcomes: perceived risk and distress after counseling for hereditary colorectal cancer.

Authors:  Ann-Marie Codori; Tracy Waldeck; Gloria M Petersen; Diana Miglioretti; Jill D Trimbath; Miriam A Tillery
Journal:  J Genet Couns       Date:  2005-04       Impact factor: 2.537

4.  Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico.

Authors:  Wilfredo E De Jesus-Monge; Carmen Gonzalez-Keelan; Ronghua Zhao; Stanley R Hamilton; Miguel Rodriguez-Bigas; Marcia Cruz-Correa
Journal:  Fam Cancer       Date:  2010-06       Impact factor: 2.375

5.  Inherited colorectal cancer syndromes.

Authors:  C Neal Ellis
Journal:  Clin Colon Rectal Surg       Date:  2005-08

6.  Mutational analysis of OGG1, MYH, MTH1 in FAP, HNPCC and sporadic colorectal cancer patients: R154H OGG1 polymorphism is associated with sporadic colorectal cancer patients.

Authors:  I-J Kim; J-L Ku; H C Kang; J-H Park; K-A Yoon; Y Shin; H-W Park; S G Jang; S-K Lim; S Y Han; Y-K Shin; M R Lee; S-Y Jeong; H-R Shin; J S Lee; W-H Kim; J-G Park
Journal:  Hum Genet       Date:  2004-09-24       Impact factor: 4.132

7.  Lynch syndrome (HNPCC).

Authors:  Józef Kladny; Jan Lubinski
Journal:  Hered Cancer Clin Pract       Date:  2008-06-15       Impact factor: 2.857

8.  Nuclear Pedigree Criteria for the Identification of Individuals Suspected to be at Risk of an Inherited Predisposition to Renal Cancer.

Authors:  Aleksandra Tołoczko-Grabarek; Andrzej Sikorski; Marek Brzosko; Jan Lubiński
Journal:  Hered Cancer Clin Pract       Date:  2005-08-15       Impact factor: 2.857

9.  Some aspects of molecular diagnostics in Lynch syndrome.

Authors:  Grzegorz Kurzawski
Journal:  Hered Cancer Clin Pract       Date:  2006-12-15       Impact factor: 2.857

Review 10.  [Molecular pathology in hereditary colorectal cancer. Recommendations of the Collaborative German Study Group on hereditary colorectal cancer funded by the German Cancer Aid (Deutsche Krebshilfe)].

Authors:  J Rüschoff; B Roggendorf; F Brasch; M Mathiak; D E Aust; J Plaschke; W Mueller; C Poremba; M Kloor; G Keller; M Muders; S Blasenbreu-Vogt; P Rümmele; A Müller; R Büttner
Journal:  Pathologe       Date:  2004-05       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.